Načítá se...

2422. Efficacy of Cefoxitin for the Treatment of Urinary Tract Infection (UTI) Due to ESBL-Producing E. coli and K. pneumoniae Isolates

BACKGROUND: Cefoxitin has a good in vitro activity and stability in resistance to hydrolysis by ESBLs, and is a good candidate for the treatment of urinary tract infection (UTI). However, data are scarce regarding its use in clinical practice, especially against K. pneumoniae deemed to be capable of...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Open Forum Infect Dis
Hlavní autoři: Senard, Olivia, Bouchand, Frederique, Deconinck, Laurene, Matt, Morgan, Fellous, Lesly, Rottman, Martin, Perronne, Christian, Dinh, Aurelien, Davido, Benjamin
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2018
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6253686/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.2075
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!